Next Issue
Volume 10, 01
Previous Issue
Volume 9, 11
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 9, Issue 12 (12 2006) – 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
2 pages, 288 KB  
Review
European Society of Cardiology: Textbook of Cardiovascular Medicine
by Georg Noll
Cardiovasc. Med. 2006, 9(12), 441; https://doi.org/10.4414/cvm.2006.01216 - 29 Dec 2006
Viewed by 10
Abstract
Die Europäische Gesellschaft für Kardiologie (ESC) hat als erste Fachgesellschaft ein europäisches Lehrbuch über die gesamte kardiovaskuläre Medizin herausgegeben[...] Full article
2 pages, 224 KB  
Interesting Images
Accessory Mitral Valve Tissue
by Anja Faeh, Pablo Anabitarte and Jürgen Frielingsdorf
Cardiovasc. Med. 2006, 9(12), 439; https://doi.org/10.4414/cvm.2006.01215 - 29 Dec 2006
Cited by 1 | Viewed by 9
Abstract
Accessory mitral valve tissue is a rare congenital malformation. It can be found isolated or in combination with other cardiac anomalies and is usually detected in early childhood. We describe the case of a 74-year-old asymptomatic patient who was referred to our clinic [...] Read more.
Accessory mitral valve tissue is a rare congenital malformation. It can be found isolated or in combination with other cardiac anomalies and is usually detected in early childhood. We describe the case of a 74-year-old asymptomatic patient who was referred to our clinic for the evaluation of a heart murmur. Full article
1 pages, 186 KB  
Interesting Images
Douleurs Précordiales Récidivantes
by Jürg Schläpfer
Cardiovasc. Med. 2006, 9(12), 438; https://doi.org/10.4414/cvm.2006.01217 - 29 Dec 2006
Viewed by 15
Abstract
Description du cas. Patient de 57 ans, hypertendu sous bétabloquant, hypercholéstérolémique, présentant des douleurs précordiales typiques récidivantes disparaissant à la prise de trinitrine [...] Full article
5 pages, 902 KB  
Case Report
Ein Gebrochenes Herz nach einem Streit mit der Schwiegermutter: Die Stressinduzierte Kardiomyopathie
by Lukas Spieker, Peter Burger, Thomas Ritschard, Christof Noti and Roberto Corti
Cardiovasc. Med. 2006, 9(12), 433; https://doi.org/10.4414/cvm.2006.01214 - 29 Dec 2006
Cited by 1 | Viewed by 8
Abstract
A 59-year-old woman with chest pain after a controversy with her mother-in-law, ECG changes and positive troponine was transferred to our clinic for emergency coronary angiography. Angiography showed open coronary arteries and midventricular akinesia of the left ventricle. These findings are typical for [...] Read more.
A 59-year-old woman with chest pain after a controversy with her mother-in-law, ECG changes and positive troponine was transferred to our clinic for emergency coronary angiography. Angiography showed open coronary arteries and midventricular akinesia of the left ventricle. These findings are typical for stressinduced cardiomyopathy. This entity is also named Tako-Tsubo cardiomyopathy and has gained attention as a differential diagnosis of acute coronary syndrome. Typically, akinetic zones cannot be attributed to a single coronary territory. The underlying pathophysiological mechanisms may include microvascular spasm induced by excessive catecholamine release. Characteristically, only minimal increases of myocardial damage is documented by biochemical markers (CK, troponine). This is in contrast to often extensive ventricular akinetic regions possibly resulting in haemodynamic instability and need for inotropic support. Typically the myocardium remains viable, as can be shown by cardiac magnetic resonance tomography, and impaired ventricular function completely recovers over weeks. Full article
7 pages, 303 KB  
Article
ICD-Kontroverse: Braucht Jeder Patient Mit Einer Linksventrikulären Auswurffraktion unter 35% einen ICD?
by Richard Kobza, Paul Erne, Christoph Scharf and Firat Duru
Cardiovasc. Med. 2006, 9(12), 426; https://doi.org/10.4414/cvm.2006.01213 - 29 Dec 2006
Viewed by 9
Abstract
Sudden cardiac death (SCD) is a major healthcare problem worldwide. The left ventricular ejection fraction is the most important predictor of SCD in patients with ischaemic and nonischaemic cardiomyopathy. Implantable cardioverter defibrillator (ICD) therapy prevents SCD in specific patient populations and various studies [...] Read more.
Sudden cardiac death (SCD) is a major healthcare problem worldwide. The left ventricular ejection fraction is the most important predictor of SCD in patients with ischaemic and nonischaemic cardiomyopathy. Implantable cardioverter defibrillator (ICD) therapy prevents SCD in specific patient populations and various studies have analysed the efficacy of the ICD to prevent SCD. The purpose of this article is to describe the evidence supporting the use of ICD therapy and to discuss, whether all patients with an ejection fraction ≤35% should receive an ICD. Full article
8 pages, 945 KB  
Proceeding Paper
Programmation Optimale des Stimulateurs Multisites et Suivi des Patients Après Thérapie de Resynchronisation Cardiaque
by Grégoire Girod, Andreï Forclaz and Xavier Lyon
Cardiovasc. Med. 2006, 9(12), 418; https://doi.org/10.4414/cvm.2006.01219 - 29 Dec 2006
Viewed by 13
Abstract
While substantial progress has been made over the past decade in the medical treatment of heart failure, certain patients fail to respond to optimal treatment despite the availability of excellent drugs. Cardiac resynchronisation therapy, or multisite pacing, appears to offer great hope for [...] Read more.
While substantial progress has been made over the past decade in the medical treatment of heart failure, certain patients fail to respond to optimal treatment despite the availability of excellent drugs. Cardiac resynchronisation therapy, or multisite pacing, appears to offer great hope for certain patients with dilated cardiomyopathy of idiopathic or ischaemic origin with signs of cardiac dyssynchrony, usually in the form of a widened QRS complex on the surface ECG. This new therapy has been shown to produce definite beneficial effects on the symptoms of patients, improving the functional class and walking distance in particular, and also prolonging survival. The optimal programming of the multisite pacemaker is a crucial aspect of this new treatment and requires a meticulous approach, the practical implications of which are addressed in this article. Full article
5 pages, 178 KB  
Editorial
Drug-Eluting Stent-Thrombosen—Unterschätztes Problem Oder Übertriebene Angst?
by Jan Steffel, Franz R. Eberli, Felix C. Tanner and Thomas F. Lüscher
Cardiovasc. Med. 2006, 9(12), 413; https://doi.org/10.4414/cvm.2006.01218 - 29 Dec 2006
Viewed by 9
Abstract
Einleitung. Die koronare Herzkrankheit und der akute Myokardinfarkt (AMI) gehen mit einer hohen Morbidität und Mortalität einher [1]; die perkutane Koronarintervention (PCI) stellt die bevorzugte Behandlungsmethode des AMI dar [2] [...] Full article
Previous Issue
Next Issue
Back to TopTop